NCT07494565
- Conditions
- CD5 Positive, Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,772 public trials
697 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT06742996
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- Ucsf Fresno Fresno, California, United States
- Kaiser Permanente Southern California Irvine, California, United States
NCT06542250
- Conditions
- B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Rochester, Minnesota, United States
- Research Site Hackensack, New Jersey, United States
NCT07154823
- Conditions
- Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL), Hematologic Diseases, +15 more
- Locations
-
- University of Iowa Hospital and Clinics Iowa City, Iowa, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
- Washington University in St. Louis St Louis, Missouri, United States
- Cancer Care Specialists of Reno Reno, Nevada, United States
NCT07205315
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
- Locations
-
- Zhengzhou Yihe Hospital Zhengzhou, Henan, China
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
NCT07409428
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Baoding NO.1 Central Hospital Baoding, China
- Beijing GoBroad Hospital Beijing, China
- BEIJING TONGREN HOSPITAL, Capital Medical University Beijing, China
NCT06863402
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT06471738
- Conditions
- Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma, +13 more
- Locations
-
- Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital Beijing, China
NCT03011814
- Conditions
- Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Anchorage, Alaska, United States
- Research Site Phoenix, Arizona, United States
- Research Site Clovis, California, United States